Hsbc Holdings PLC Takes $508,000 Position in Prestige Consumer Healthcare Inc. $PBH

Hsbc Holdings PLC purchased a new stake in Prestige Consumer Healthcare Inc. (NYSE:PBH) in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 10,683 shares of the company’s stock, valued at approximately $508,000.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. BlackRock Inc. bought a new stake in Prestige Consumer Healthcare during the 2nd quarter worth about $370,187,000. Rice Hall James & Associates LLC acquired a new stake in Prestige Consumer Healthcare in the 2nd quarter valued at about $32,602,000. The Manufacturers Life Insurance Company bought a new position in shares of Prestige Consumer Healthcare in the second quarter worth about $31,135,000. Norges Bank bought a new position in shares of Prestige Consumer Healthcare in the fourth quarter worth about $36,954,000. Finally, Bank of New York Mellon Corp acquired a new position in shares of Prestige Consumer Healthcare during the second quarter worth approximately $15,376,000. Institutional investors and hedge funds own 99.95% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on PBH. Canaccord Genuity Group lowered their price target on shares of Prestige Consumer Healthcare from $86.00 to $72.00 and set a “buy” rating for the company in a report on Friday, May 15th. Oppenheimer lowered Prestige Consumer Healthcare from an “outperform” rating to a “market perform” rating in a research report on Thursday, May 14th. Zacks Research upgraded Prestige Consumer Healthcare from a “strong sell” rating to a “hold” rating in a research report on Monday, August 10th. Finally, Weiss Ratings lowered Prestige Consumer Healthcare from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Thursday, June 25th. Two analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $70.75.

Prestige Consumer Healthcare Price Performance

PBH opened at $52.91 on Thursday. The company has a fifty day moving average price of $50.59 and a two-hundred day moving average price of $54.25. The firm has a market capitalization of $2.51 billion, a PE ratio of 14.82, a P/E/G ratio of 1.65 and a beta of 0.33. Prestige Consumer Healthcare Inc. has a 52 week low of $42.62 and a 52 week high of $71.07. The company has a debt-to-equity ratio of 1.06, a quick ratio of 1.99 and a current ratio of 3.23.

Prestige Consumer Healthcare (NYSE:PBH) last posted its quarterly earnings results on Thursday, August 6th. The company reported $0.98 earnings per share for the quarter, beating analysts’ consensus estimates of $0.89 by $0.09. Prestige Consumer Healthcare had a return on equity of 11.39% and a net margin of 15.57%.The company had revenue of $265.71 million for the quarter, compared to the consensus estimate of $253.02 million. During the same quarter in the prior year, the business posted $0.90 EPS. The firm’s quarterly revenue was up 6.5% on a year-over-year basis. Prestige Consumer Healthcare has set its FY 2027 guidance at 4.550-4.650 EPS. As a group, analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.56 earnings per share for the current year.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare, Inc is a leading manufacturer and marketer of branded over-the-counter (OTC) healthcare products. The company focuses on developing, acquiring and commercializing a diverse portfolio of non-prescription remedies designed to address common consumer health needs, including pain relief, cold and cough, digestive health, eye care, skin care and women’s health.

Key brands in Prestige’s portfolio include Clear Eyes (eye health), Carmex (lip care), Chloraseptic (sore throat relief), Dramamine (motion sickness), Rolaids (antacid), Monistat (women’s health), BC Powder (pain relief), Little Remedies (pediatric cold and gas relief) and TheraTears (dry eye therapy).